With regard to DNA methylation, the circulating tumor DNA methylation of MYO1G has been reported to be a promising biomarker for the diagnosis and disease monitoring of colorectal cancer (22) and Hepatocellular Carcinoma (23). The gene discussed is MYO1G; the disease is hepatocellular carcinoma.